ArticleBMC nephrology2026
Multimodal biomarker approach using urinary prostaglandin E2, kidney injury molecule-1 and resistive index for assessing kidney adaptation in transplant recipients.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney transplantation is the standard treatment for end-stage renal disease (ESRD). Traditional monitoring with serum creatinine and renal biopsy is limited by delayed detection and invasiveness. Urinary biomarkers including prostaglandin E2 (PGE2) and kidney injury molecule-1 (KIM-1), together with doppler resistive index (RI) may detect early allograft adaptation and subclinical injury. This study aims to evaluate the potential of PGE2, KIM-1 and RI in reflecting post-transplant kidney adaptation.
methodsWe conducted a prospective study of 59 adult living-donor kidney transplant recipients in 2023-2024. Urine and blood were collected pre-transplant and serially post-transplant within 3 months. PGE2 was measured at baseline, day 2, and 1 month, while KIM-1 was analyzed at 1 week. Primary outcome was functional delayed graft function (fDGF). Associations with glomerular filtration rate and resistive index were analyzed using correlation and multivariate regression.
resultsUrinary PGE2 on postoperative day 2 was significantly higher in patients with immediate graft function (IGF) and showed the best diagnostic value for fDGF (AUC 0.655; sensitivity 82%; specificity 52%). Urinary KIM-1 was not significantly different between groups and limited predictive value (AUC 0.647). RI at both segmental and arcuate arteries during the first postoperative week was significantly higher in recipients with fDGF (p = 0.045 and p = 0.028, respectively). Day-2 PGE2 correlated with 1st month RI whereas preoperative PGE2 correlated with 1st month postoperative RI at segmental but not arcuate arteries. Multivariate regression reveals KIM-1 and preoperative biomarkers were not predictive while 1-month PGE2 independently predicted 3-month eGFR.
conclusionsElevated urinary PGE2 may reflect adaptive hyperfiltration and showed modest predictive value for early graft function. The resistive index was associated with fDGF, while KIM-1 showed inconsistent associations. These findings suggest potential complementary roles of PGE2 and resistive index in the early assessment of kidney transplant adaptation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.